Cycles of Aberrant Synaptic Sprouting and Neurodegeneration in Alzheimer's and Dementia with Lewy Bodies
The DOI matches its Crossref record; 151 of the 156 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are the most common neurodegenerative disorders affecting the elderly. The cognitive and motor deficits in these diseases are associated with the disruption of neuritic substructure, loss of synaptic contacts in selectively vulnerable circuitries, and aberrant sprouting. Where as in AD, accumulation of misfolded forms of Abeta triggers neurodegeneration, in DLB accumulation of alpha-synuclein might play a central role. The mechanisms by which oligomeric forms of these proteins might lead to cycles of synapse loss and aberrant sprouting are currently under investigation. Several possibilities are being considered, including mitochondrial damage, caspase activation, lysosomal leakage, fragmentation of the Golgi apparatus, interference with synaptic vesicle transport and function, and interference with gene transcription and signaling. Among them, recent lines of research support the possibility that alterations in signaling pathways such extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 relevant to synaptic plasticity and cell survival might play a pivotal role. A wide range of cellular functions are affected by the accumulation of misfolded Abeta and alpha-synuclein; thus it is possible that a more fundamental cellular alteration may underlie the mechanisms of synaptic pathology in these disorders. Among them, one possibility is that scaffold proteins, such as caveolin and JNK-interac…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“7), recent studies have shown that missense mutations (Ala53 to Thr, Ala30 to Pro) in -synuclein are associated with familial parkinsonism (125,126) and that mutant (mut) -synuclein is more prone to aggregate (127–129) and is the principal component of the LBs (120,122).”
BackgroundGoate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Self-citationMcKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Srimaroeng, C., Cecile, J. P., Walden, R., & Pritchard, J. B. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350077 · Cited by 2,989
Research works printed but not linked: 9
- Eccles, J. 1984. The cerebral neocortex: A theory of its operation. Pages 1-38, in Jones, E. and Peters, A. (eds.), Cerebral Cortex, Vol. 2, Functional Properties of Cortical Cells, New York, Plenum.
- Cotman, C. and Nadler, J. 1978. Reactive synaptogenesis in the hippocampus. Pages 227-271, in Cotman, C. (ed.), Neuronal Plasticity, New York, Raven.
- Cotman, C., Cummings, B., and Pike, C. 1993. Molecular cascades in adaptive versus pathological plasticity. Pages 217-240, in Gorio, A. (ed.), Neurodegeneration, New York, Raven.
- Terry, R., Hansen, L., and Masliah, E. 1994. Structural basis of the cognitive alterations in Alzheimer disease. Pages 179-196, in Terry, R. and Katzman, R. (eds.), Alzheimer Disease, New York, Raven.
- Masliah, E. and LiCastro, F. 2000. Neuronal and synaptic loss, reactive gliosis, microglial response, and induction of the complement cascade in Alzheimer's disease. Pages 131-146, in Clark, C. and Trojanowski, J. Neurodegenerative Dementias, New York, McGraw-Hill.
- Hof, P. and Morrison, J. 1994. The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. Pages 197-230, in Terry, R., Katzman, R., and Bick, K. (eds.), Alzheimer Disease, New York, Raven.
- Anderson, B. 1995. Dendritic correlates of dementia severity in Alzheimer's disease. Med. Sci. Res. 23:597-599.
- Masliah, E. and Terry, R. 1994. The role of synaptic pathology in the mechanisms of dementia in Alzheimer's disease. Clin. Neurosci. 1:192-198.
- Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., and Mucke, L. 2001. Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl. Acad. Sci. USA 98:12245-12250. · DOI · Paper page
Cited by
Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Garcia‐Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04613.x · Cited by 661
Spencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T., & Masliah, E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4390-09.2009 · Cited by 595
“This model was selected because overexpression of -syn in these cells results in mitochondrial alterations, reduced cell viability, defective neurite outgrowth, and abnormal accumulation of oligomeric -syn (Takenouchi et al., 2001; Hashimoto and Masliah, 2003).”
BackgroundSelf-citationFunctional Alterations in Memory Networks in Early Alzheimer’s Disease
Sperling, R. A., Dickerson, B. C., Pihlajamaki, M., Vannini, P., LaViolette, P. S., Vitolo, O. V., Hedden, T., Becker, J. A., Rentz, D. M., Selkoe, D. J., et al. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8109-7 · Cited by 604
“Alternatively, increased regional brain activation may be a marker of the pathophysiologic process of AD itself, such as aberrant sprouting of cholinergic fibers (Hashimoto and Masliah 2003) or inefficiency in synaptic transmission (Stern et al. 2004).”
BackgroundMedial temporal lobe function and structure in mild cognitive impairment
Dickerson, B. C., Salat, D. H., Bates, J. F., Atiya, M., Killiany, R. J., Greve, D. N., Dale, A. M., Stern, C. E., Blacker, D., Albert, M. S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20163 · Cited by 566
Dickerson, B. C., & Sperling, R. A. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.11.030 · Cited by 376
Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline
O'Brien, J. L., O'Keefe, K. M., LaViolette, P. S., DeLuca, A. N., Blacker, D., Dickerson, B. C., & Sperling, R. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e3966e · Cited by 299
Apolipoproteins in the brain: implications for neurological and psychiatric disorders
Elliott, D. A., Weickert, C. S., & Garner, B. (2010) · Clinical Lipidology · doi:10.2217/clp.10.37 · Cited by 194
“This is of interest when it is considered that neuritic dysfunction is a major part of many neurodegenerative illnesses [156,157].”
BackgroundSpontaneous Age-Related Neurite Branching in Caenorhabditis elegans
Tank, E. M. H., Rodgers, K. E., & Kenyon, C. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6606-10.2011 · Cited by 176
“Although many human neurodegenerative diseases are characterized by atrophy and neuronal loss, neurite sprouting has been observed in diseased brains (Masliah et al., 1993; Hashimoto and Masliah, 2003; Gordon et al., 2004).”
BackgroundWalton, J. R., & Wang, M.-X. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.07.027 · Cited by 158
Poon, H. F., Vaishnav, R., Getchell, T. V., Getchell, M. L., & Butterfield, D. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.006 · Cited by 143
“Thus, the increased expression of DNM1 in the brains of old mice may indicate increased synaptic vesicle recycling associated with increased synaptic plasticity as a compensatory response to age-related synaptic loss such as that proposed to occur in neurodegenerative diseases [ 21 ].”
Martin, B., Brenneman, R., Becker, K. G., Gucek, M., Cole, R. N., & Maudsley, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002750 · Cited by 113
“In the initial stages of AD, the neurodegenerative process may target the synaptic terminals [5,6] and then propagate to axons and dendrites, leading to neuronal dysfunction and eventually to neuronal death [7].”
BackgroundNeuronal Structure is Altered by Amyloid Plaques
Spires, T. L., & Hyman, Β. Τ. (2004) · Reviews in the Neurosciences · doi:10.1515/revneuro.2004.15.4.267 · Cited by 109
Ferrer, I., Kapfhammer, J. P., Hindelang, C., Kemp, S., Troffer-Charlier, N., Broccoli, V., Callyzot, N., Mooyer, P., Selhorst, J., Vreken, P., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi384 · Cited by 106
“Mitochondrial damage has also been found associated with aberrant sprouting and synapse loss in AD and dementia with Lewy bodies (39).”
BackgroundFerrer, I. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.004 · Cited by 123
Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model
Garcia-Alloza, M., Dodwell, S. A., Meyer-Luehmann, M., Hyman, B. T., & Bacskai, B. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240468.12543.af · Cited by 99
“It is thus well-established that the altered microenvironment around plaques is responsible to some extent for the pathologic neurites present in AD brains (11).”
BackgroundGondard, E., Chau, H. N., Mann, A., Tierney, T. S., Hamani, C., Kalia, S. K., & Lozano, A. M. (2015) · Brain stimulation · doi:10.1016/j.brs.2015.07.044 · Cited by 99
“AD is characterized by loss of synapses [39,40] and reductions in synaptophysin expression in frontal, parietal, occipital and temporal cortex and hippocampus of patients [41,42].”
BackgroundNeurochemistry and the non-motor aspects of PD
Ferrer, I., López-Gonzalez, I., Carmona, M., Dalfó, E., Pujol, A., & Martínez, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.019 · Cited by 87
“Altered metabolic events at the synapses may impair synaptic function and aberrant synaptic plasticicity in PD (Hashimoto and Masliah, 2003).”
BackgroundNguyen, T. V., Galvan, V., Huang, W., Banwait, S., Tang, H., Zhang, J., & Bredesen, D. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05031.x · Cited by 75
“2004), Ab-induced synaptic dysfunction (Savage et al. 2002; Hashimoto and Masliah 2003; Costello and Herron 2004; Xie 2004), and oxidative stress damage (de la Monte et al.”
BackgroundSingh, I. N., El‐Hage, N., Campbell, M. E., Lutz, S. E., Knapp, P. E., Nath, A., & Hauser, K. F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.028 · Cited by 74
“, 2004), in addition to promoting both degenerative or regenerative processes (Herdegen and Waetzig, 2001; Hashimoto and Masliah, 2003).”
BackgroundCarr, V. A., Bernstein, J. D., Favila, S. E., Rutt, B. K., Kerchner, G. A., & Wagner, A. D. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713308114 · Cited by 84
α-Synuclein Aggregates Interfere with Parkin Solubility and Distribution
Kawahara, K., Hashimoto, M., Bar-On, P., Ho, G. J., Crews, L., Mizuno, H., Rockenstein, E., Imam, S. Z., & Masliah, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710418200 · Cited by 64
Self-citationROCK, PAK, and Toll of synapses in Alzheimer’s disease
Salminen, A., Suuronen, T., & Kaarniranta, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.148 · Cited by 71
Spencer, B., Kim, C., Gonzalez, T., Bisquertt, A., Patrick, C., Rockenstein, E., Adame, A., Lee, S.-J., Desplats, P., & Masliah, E. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv633 · Cited by 58
“in these cells results in mitochondrial alterations, reduced cell viability, defective neurite outgrowth and abnormal accumulation of oligomeric α-syn (67).”
BackgroundSelf-citationA role for caveolin‐1 in post‐injury reactive neuronal plasticity
Gaudreault, S. B., Blain, J., Gratton, J., & Poirier, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02917.x · Cited by 61
“For example, the up-regulated caveolin-1 level in Alzheimer’s disease brain (Gaudreault et al. 2004b), might be, at least in part, responsible for the proposed misdirected reactive sprouting in the pathology (Hashimoto and Masliah 2003).”
BackgroundSontag, J., Nunbhakdi‐Craig, V., Mitterhuber, M., Ogris, E., & Sontag, E. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07049.x · Cited by 57
“Notably, neuritic abnormalities and disruption leading to axonal transport defects are associated with pathological lesions in AD and other neurodegenerative disorders (Hashimoto and Masliah 2003; Stokin and Goldstein 2006).”
BackgroundGlutamate Transporter GLT1 Expression in Alzheimer Disease and Dementia With Lewy Bodies
Garcia-Esparcia, P., Diaz-Lucena, D., Ainciburu, M., Torrejón-Escribano, B., Carmona, M., Llorens, F., & Ferrer, I. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00122 · Cited by 55
“Since synaptic connectivity is reduced in frontal cortex in AD and DLB (Jellinger, 2000; Selkoe, 2002; Hashimoto and Masliah, 2003; Gong and Lippa, 2010; Schulz-Schaeffer, 2010; Ferrer, 2012; de Wilde et al., 2016; Santpere et al., 2017), the possibility of reduced GLT1 expression secondary to…”
BackgroundNewman, J., Rissman, R. A., Sarsoza, F. M., Kim, R. C., Dick, M. B., Bennett, D. A., Cotman, C. W., Rohn, T. T., & Head, E. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1027-3 · Cited by 63
“The accumulation of a-synuclein may lead to mitochondrial dysfunction, subsequent release of cytochrome C and the activation of caspase-9 [17].”
BackgroundGarcia-Esparcia, P., López-González, I., Grau-Rivera, O., García-Garrido, M. F., Konetti, A., Llorens, F., Zafar, S., Carmona, M., del Rio, J. A., Zerr, I., et al. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00089 · Cited by 53
“Arch Pharm Res (2010) 2010(33):1539–56.”
Genetics of primary open angle glaucoma
Takamoto, M., & Araie, M. (2013) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-013-0286-0 · Cited by 56
“Caveolin 1 and caveolin 2 (CAV1/ CAV2) Expression in the trabecular meshwork and retinal ganglion cells [136] involvement in other neurodegenerative diseases [212, 213] possible interaction with synuclein family which is expressed in TM cells and participates in glaucomatous alterations [214–216]”
BackgroundMasliah, E., Xie, F., Dayan, S., Rockenstein, E., Mante, M., Adame, A., Patrick, C. M., Chan, A. F., & Zheng, B. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.045 · Cited by 51
Self-citationNellessen, N. D., Rottschy, C., Eickhoff, S. B., Ketteler, S. T., Kuhn, H., Shah, N. J., Schulz, J. B., Reske, M., & Reetz, K. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0744-6 · Cited by 50
“For instance, hyperactivation was associated with aberrant sprouting of cholinergic fibres (Hashimoto and Masliah 2003), excitotoxicity from the excessive stimulation of NMDA receptors (Hynd et al. 2004) or stress from Ab-induced neuronal alterations (e.g. excitatory activation triggers…”
Backgroundvon Gunten, A., Kövari, E., Rivara, C., Bouras, C., Hof, P. R., & Giannakopoulos, P. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.005 · Cited by 52
Ba, I. A.-T. V., Marchal, S., François, F., Silhol, M., Lleres, C., Michel, B. F., Benyamin, Y., Verdier, J., Trousse, F., & Marcilhac, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.260349 · Cited by 49
Narayana, P. A., Herrera, J. J., Bockhorst, K. H. J., Esparza‐Coss, E., Xia, Y., Steinberg, J. L., & Moeller, F. G. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.01.005 · Cited by 42
Hwang, Y. K., Ma, J., Choi, B., Cui, C., Jeon, W. K., Kim, H., Kim, H. Y., Han, S., & Han, J. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.06.025 · Cited by 43
Villemagne, V. L. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.142 · Cited by 43
Surgucheva, I. G., & Surguchov, A. P. (2011) · PubMed Central · Cited by 42
Kukolja, J., Thiel, C. M., Eggermann, T., Zerres, K., & Fink, G. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.044 · Cited by 40
Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice
García-Alloza, M., Borrelli, L. A., Hyman, B. T., & Bacskai, B. J. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.006 · Cited by 48
“, 2008) and it seems that the altered microenvironment around plaques is responsible to some extent for the pathological neurites present in AD brains (for review see Hashimoto and Masliah (Hashimoto and Masliah, 2003)).”
BackgroundInfluentialSong, J., Qu, R., Sun, B., Chen, R., Kan, H., An, Z., Jiang, J., Li, J., Zhang, Y., & Wu, W. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c03754 · Cited by 38
Neuritic Pathology as a Correlate of Synaptic Loss in Dementia With Lewy Bodies
Revuelta, G. J., Rosso, A., & Lippa, C. F. (2008) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317507310565 · Cited by 35
“Some possibilities include mitochondrial damage, caspase activation, lysosomal leakage, fragmentation of the Golgi apparatus, synaptic vesicle dysfunction, transport abnormalities, as well as signaling pathway dysfunction.(18) One study that showed synaptic loss in LBV to be equal to that of AD, found there to be more…”
BackgroundCaveolin isoform expression during differentiation of C6 glioma cells
Silva, W. I., Maldonado, H. M., Velazquez, G., Rubio-Dávila, M. M., Miranda, J. D., Aquino, E. E., Mayol, N., Cruz‐Torres, A., Jardón, J., & Salgado, I. K. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.07.007 · Cited by 34
Novel strategies for Alzheimer's disease treatment
Spencer, B. J., Rockenstein, E. M., Crews, L. A., Marr, R. A., & Masliah, E. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.12.1853 · Cited by 32
“In the initial stages of AD, the neurodegenerative process targets the synaptic terminals [6-8] and then propagates to axons and dendrites, leading to neuronal dysfunction and eventually to neuronal death [9] .”
BackgroundSelf-citationBeauchamp, L. C., Doré, V., Villemagne, V. L., Xu, S., Finkelstein, D. I., Barnham, K. J., & Rowe, C. C. (2023) · Neurology · doi:10.1212/wnl.0000000000207748 · Cited by 30
“16,17 Finally, given the extensive synaptic loss that has occurred by the time of clinical diagnosis, representation of the prodromal phase with a cohort of participants at greater risk of developing PD, such as those with REM sleep behavior disorder (RBD), will provide insight into the early…”
BackgroundBACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice
Yan, X.-X., Cai, Y., Zhang, X.-M., Luo, X.-G., Cai, H., Rose, G. M., & Patrylo, P. R. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.003 · Cited by 31
“, 1989) and Alzheimer's disease (AD) (Akram, et al., 2008; Arendt, 2001; Cai, et al., 2010; Geddes and Cotman, 1991; Hashimoto and Masliah, 2003; Moolman, et al., 2004; Shim and Lubec, 2002; Stokin, et al., 2005).”
Duquette, A., Pernègre, C., Carpentier, A. V., & Leclerc, N. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.607680 · Cited by 43
“Interestingly, axonal and dendritic sprouting was observed in AD indicating that neurons might attempt to re-growth their axon and re-establish synaptic contacts (74, 75).”
BackgroundNelson, A. R., Kolasa, K., & McMahon, L. L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130608 · Cited by 26
“Additionally, cholinergic sprouting has been demonstrated in close proximity to Aβ plaques in AD post-mortem human brain tissue, although whether this cholinergic sprouting is a consequence of noradrenergic sympathetic sprouting as in rats is not currently known [22, 23].”
Beauchamp, L. C., Villemagne, V. L., Finkelstein, D. I., Doré, V., Bush, A. I., Barnham, K. J., & Rowe, C. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-74495-x · Cited by 23
FMRI: Use in Early Alzheimer‘s Disease and in Clinical Trials
Pihlajamaki, M. M., & Sperling, R. A. (2008) · Future Neurology · doi:10.2217/14796708.3.4.409 · Cited by 23
“The neural basis of fMRI hyperactivation is not fully known but the hyperactivation finding is, for example, consonant with reports of aberrant sprouting of cholinergic fibers [55], inefficiency of synaptic transmission [56] and upregulated hippocampal choline acetyltransferase activity in MCI [57], which may in turn…”
BackgroundAlzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 30
Neill, D. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.06.004 · Cited by 25
Jellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_15 · Cited by 25
Bertoni–Freddari, C., Fattoretti, P., Giorgetti, B., Grossi, Y., Balietti, M., Casoli, T., Stefano, G. D., & Perretta, G. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.078 · Cited by 17
Ferrera, P., Zepeda, A., & Arias, C. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0467-3 · Cited by 17
“Ab has been implicated not only in neuronal damage, synapse, and neurite collapse but also in the increase of aberrant neuronal sprouting (Masliah et al. 1993; Hashimoto and Masliah 2003).”
BackgroundSV2 frustrating exocytosis at the semi‐diffusor synapse
Vautrin, J. (2009) · Synapse · doi:10.1002/syn.20610 · Cited by 12
Liu, H., Wolters, A., Temel, Y., Alosaimi, F., Jahanshahi, A., & Hescham, S. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105797 · Cited by 12
“The characteristic of AD is loss of synapses, and the reduced expression of the synaptophysin in the frontal, parietal, occipital and temporal cortex, and hippocampus of patients [57-60].”
Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease
Hashimoto, M., Ho, G. J., Takamatsu, Y., Wada, R., Sugama, S., Takenouchi, T., Waragai, M., & Masliah, E. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191675 · Cited by 11
“Furthermore, in dementia with Lewy bodies (DLB) as well as familial AD, S aggregates frequently co-localize with those of A [12, 13].”
BackgroundSelf-citationGáspárová, Z., Stara, V., Janega, P., Navarová, J., Sedláčková, N., Mach, M., & Ujházy, E. (2014) · PubMed · Cited by 10
fMRI in Neurodegenerative Diseases: From Scientific Insights to Clinical Applications
Dickerson, B. C., Agosta, F., & Filippi, M. (2016) · Neuromethods · doi:10.1007/978-1-4939-5611-1_23 · Cited by 8
Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer’s Disease
Quiroz, Y. T., Celone, K., Castrillón, G., Muniz, M. C., Lopera, F. J., Budson, A. E., & Stern, C. E. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150214 · Cited by 8
“There is also evidence indicating that hippocampal hyperactivity might possibly reflect inefficient synaptic transmission [33], or abnormal sprouting of cholinergic fibers [34].”
Qiu, Q. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903269 · Cited by 8
“Increased activity may be partially explained by neuro hypertrophy, neuroinflammation, and fiber sprouting during the compensatory stage of pathophysiology (Hashimoto and Masliah, 2004; Stern et al., 2004; Sperling et al., 2010; Zott et al., 2018).”
BackgroundGarcía-García, E., Ramón-Lainez, A., Conde-Berriozabal, S., del Toro, D., Escaramís, G., Giralt, A., Masana, M., Alberch, J., & Rodríguez, M. J. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106292 · Cited by 5
McCoy, P. A., & McMahon, L. L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.027 · Cited by 5
“In fact, it may be the unidentified “abberant sprouting” that some suggest is responsible for the increased cholinergic function (Hashimoto and Masliah, 2003, Masliah et al., 2003).”
BackgroundfMRI in Neurodegenerative Diseases: From Scientific Insights to Clinical Applications
Dickerson, B. C. (2009) · Neuromethods · doi:10.1007/978-1-60327-919-2_22 · Cited by 3
Innate and Adaptive Immunity in Health and Disease
Gendelman, H. E., & Masliah, E. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_2 · Cited by 1
Self-citationApplications of fMRI to Neurodegenerative Disease
Mahmoud, S. Y., Moon, D., Lee, J. K., & Jones, S. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_36 · Cited by 1
Poon, H. F. (2005) · UKnowledge (University of Kentucky)
Applications of fMRI to Neurodegenerative Disease
Mahmoud, S. Y., Jones, S. E., & Phillips, M. D. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0345-7_32
Anatomical Networks: Structure and Function of the Nervous System
Masliah, E. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_3
Self-citationOn nogo receptors, plasticity and lasting memories
Karlsson, T. E. (2012) · Figshare
2and Adaptive Immunity in Health and Disease
Gendelman, H. E., & Masliah, E. (2008)
Self-citationApplications of fMRI to Neurodegenerative Disease
Mahmoud, S. Y., Jones, S. E., & Phillips, M. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1995-6_18
Anatomical Networks: Structure and Function of the Nervous System
Masliah, E. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_7
Self-citationInnate and Adaptive Immunity in Health and Disease
Gendelman, H. E., & Masliah, E. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_1
Self-citationfMRI in Neurodegenerative Diseases: From Scientific Insights to Clinical Applications
Dickerson, B. C., Canu, E., Tripodi, C., Agosta, F., & Filippi, M. (2025) · Neuromethods · doi:10.1007/978-1-0716-4438-6_24
Fast Fourier Transform and Dynamic Imaging of Caveolar Complex Arrays in Active Striated Muscle
Smith, K. H. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
Metadata
- Authors
- Hashimoto, M., & Masliah, E.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Masliah, Eliezer
- Venue
- Neurochemical Research
- Published
- 2003-11
- Volume
- 28
- Issue
- 11
- Pages
- 1743-1756
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W321625949
- Cited by
- 78
- References
- 156
- Citations by year
- 2025: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 2 · 2014: 4 · 2013: 2 · 2012: 2
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29ag010869-05)
- National Institute on Aging (P50AG005131, AG-5131, AG 18440, AG10869)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, dementia with Lewy bodies, synaptic loss, neurodegeneration, amyloid-beta, alpha-synuclein, protein oligomers, ERK signaling, JNK signaling, p38 MAPK, caveolin, synaptic plasticity, mitochondrial damage, Golgi fragmentation, synaptic vesicle transport, axonal plasticity
- MeSH terms
- Alzheimer Disease, Animals, Humans, Memory Disorders, Nerve Degeneration, Nerve Tissue Proteins, Neural Pathways, Synaptic Transmission, Neuronal Plasticity, Amyloid beta-Peptides, Neurites, Lewy Body Disease, Synucleins, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.